Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of a microRNA Panel to Identify Thyroid Malignancy in FNA Leftover Cells and the Effect of These microRNAs on Target Genes.

NCT01964508 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01964508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of a microRNA Panel to Identify Thyroid Malignancy in FNA Leftover Cells and the Effect of These microRNAs on Target Genes.
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Completed
Start date
September 12, 2013
Completion date
December 30, 2015
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fna, microrna, thyroid cancer, thyroid nodule